Beyond body mass index : Body composition profiling for perioperative risk stratification in intrahepatic cholangiocarcinoma patients
Cancer Reports · 2024
DOI: 10.1002/cnr2.2070 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2024. Verfasst von Johannes Kolck und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, CKV, Charité - Universitätsmedizin Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms, Body Mass Index, Body Composition. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Aims Intrahepatic cholangiocarcinoma (iCC) is an aggressive tumor, usually detected at an advanced stage. Our aim was to investigate the potential of body composition analysis (BCA) derived from presurgical staging computed tomography (CT) in predicting perisurgical complications.
Methods
In this retrospective cohort study, we enrolled 86 patients who underwent CT imaging prior to liver surgery. Cox and logistic regression were performed to assess risk factors for prolonged hospital and intensive care unit (ICU) stays, as well as the occurrence of various complications. BCA parameters served as covariates besides conventional risk factors.
Results
Postoperative complications after resection of iCC significantly prolonged the overall length of hospitalization ( p < .001). Presence of sarcopenia was associated with longer ICU stays. Complications were common, with 62.5% classified as Clavien–Dindo grade IIIa or lower and 37.5% as more severe. Subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) were identified as risk factors for complications, including bile leakage (in 24 cases, p = .025), pleural effusions (in 26 cases, p = .025), and intra‐abdominal abscess formation (in 24 cases, p = .043). SAT was associated with severe complications requiring interventional therapy, whereas VAT was correlated with abscess formation. Despite normal prevalence of obesity (22%), body mass index (BMI) did not have an impact on the development of perioperative complications.
Conclusion
BCA is a useful tool for preoperative risk stratification in patients with iCC and is superior to BMI assessment. Increased SAT and VAT were associated with the risk of perisurgical complications, prolonging hospitalization. Therefore, BCA derived from routine staging CT should be considered in the preoperative assessment of patients with iCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, CKV, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
- Department of Surgery CCM/CVK, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
ORCID-Profile: Johannes Kolck
Zitieren
APA
Kolck, J., Hosse, C., Beetz, N. L., Auer, T. A., Marth, A. A., Segger, L., Krenzien, F., Lurje, G., Pelzer, U., Geisel, D., Schöning, W., & Fehrenbach, U. (2024). Beyond body mass index : Body composition profiling for perioperative risk stratification in intrahepatic cholangiocarcinoma patients. Cancer Reports. https://doi.org/10.1002/cnr2.2070
Vancouver
Kolck J, Hosse C, Beetz NL, Auer TA, Marth AA, Segger L, et al. Beyond body mass index : Body composition profiling for perioperative risk stratification in intrahepatic cholangiocarcinoma patients. Cancer Reports. 2024. doi:10.1002/cnr2.2070
BibTeX
@article{Kolck2024,
author = {Kolck, Johannes and Hosse, Clarissa and Beetz, Nick Lasse and Auer, Timo Alexander and Marth, Adrian Alexander and Segger, Laura and Krenzien, Felix and Lurje, Georg and Pelzer, Uwe and Geisel, Dominik and Schöning, Wenzel and Fehrenbach, Uli},
title = {Beyond body mass index : Body composition profiling for perioperative risk stratification in intrahepatic cholangiocarcinoma patients},
journal = {Cancer Reports},
year = {2024},
doi = {10.1002/cnr2.2070}
}
EUVIMED